Stefani Wolff

Stefani Wolff is a seasoned pharmaceutical executive with extensive experience in product development and strategic leadership within the oncology sector. Currently serving as COO and EVP of Product Development at Nurix Therapeutics since June 2021 and as a Board Member at Rain Therapeutics, Wolff has held significant roles such as Chief Development Officer at Principia Biopharma and Vice President at Onyx Pharmaceuticals. Wolff's expertise encompasses global project team leadership and consulting within biotech and pharma environments, with a focus on development and commercialization. Educationally, Wolff holds a Bachelor of Pharmacy and a Bachelor of Science in Chemistry from the University of North Carolina at Chapel Hill.